Trump of­fi­cials seek price de­tails and weigh con­sumer sales as they ex­am­ine most fa­vored na­tion plan

Of­fi­cials in Pres­i­dent Don­ald Trump’s ad­min­is­tra­tion have spent the month since his “most fa­vored na­tion” drug price an­nounce­ment try­ing to learn more about how phar­ma …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER